Maybe too much of a good thing in gene therapy

被引:5
|
作者
Finkel, Richard S. [1 ]
Fischbeck, Kenneth H. [2 ]
机构
[1] St Jude Childrens Res Hosp, Ctr Expt Neurotherapeut, 332 N Lauderdale St, Memphis, TN 38105 USA
[2] NINDS, Neurogenet Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA
关键词
D O I
10.1038/s41593-021-00882-w
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Gene replacement therapies have shown remarkable advances recently, including onasemnogene abeparvovec for treatment of symptomatic and presymptomatic patients with spinal muscular atrophy. A recent report by Van Alstyne and colleagues in a mouse model of spinal muscular atrophy raises concerns that such treatment can generate toxic overexpression of SMN protein.
引用
收藏
页码:901 / 902
页数:2
相关论文
共 50 条